Nyxoah S.A. provided earnings guidance. Company expected a strong year-over-year growth in the first quarter, company anticipate sales to be down sequentially.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
6.96 EUR | +3.57% |
|
-1.69% | +63.38% |
02:12pm | Nyxoah Secures $40 Million Loan Facility from European Investment Bank | MT |
01/07 | Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.38% | 248M | |
+1.08% | 204B | |
+4.97% | 178B | |
+28.79% | 156B | |
+31.21% | 113B | |
+1.48% | 64.26B | |
+20.50% | 54.98B | |
-1.86% | 47.44B | |
-8.33% | 36.7B | |
-0.45% | 34.84B |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Nyxoah S.A. Provides Earnings Guidance for the First Quarter of 2024